Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, September 24, 2014

Salix contacts Actavis over potential sale-source, (NYSE: ACT), (NYSE: AGN), (NASDAQ: SLXP)

Salix Pharmaceuticals Ltd has been in contact with Actavis Plc about a potential sale to the larger drugmaker, even as Salix continues discussions with Allergan Inc about selling itself, according to a person familiar with the matter.Allergan revived discussions to purchase Salix in recent weeks after on-and-off talks for nearly a year, as it tries to fend off a hostile offer from Valeant Pharmaceuticals Inc, Reuters reported earlier this week.CNBC reported earlier Wednesday that Salix was in early-stage discussions with Actavis.Representatives for Salix and Actavis could not be immediately reached for comment.

Shares of ACT traded higher by 2.17% or $5.2199/share to $246.07. In the past year, the shares have traded as low as $136.52 and as high as $248.81. On average, 2372210 shares of ACT exchange hands on a given day and today's volume is recorded at 901056.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 2.55% or $4.3199/share to $173.50. In the past year, the shares have traded as low as $88.34 and as high as $174.49. On average, 1948020 shares of AGN exchange hands on a given day and today's volume is recorded at 931083.

Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. Shares of SLXP traded higher by 0.4% or $0.67/share to $169.84. In the past year, the shares have traded as low as $65.38 and as high as $170.71. On average, 1475300 shares of SLXP exchange hands on a given day and today's volume is recorded at 2058937.



Source